Ontario Brain Institute partners with EpiSign to advance diagnosis of rare genetic disorders
The Ontario Brain Institute (OBI) is pleased to announce a joint new initiative with EpiSign Inc., paving the way for improved diagnosis and care for people with rare neurological genetic disorders.
Alzheimer’s-related dementia could be prevented by experimental drug, researchers say
For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...
The Truth About Alzheimer’s Disease and Genes
The degenerative brain disease has no cure, and it’s only natural to ask yourself ... Early-onset Alzheimer’s can happen to ...
The Independent on MSN9d
Teenager with rare brain tumour raising funds for lifesaving treatment
This type of tumour is rare, but having it located on the third ocular nerve ... The charity has organised a month-long ...
Experimental treatment borrowed from blood cancer shows promise for pediatric brain tumors
In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...
News On 613d
4-year-old Pryor boy battles rare parasitic brain infection: How his Community is stepping up
People are coming together to rally behind the family of a Pryor boy with a rare infection caused by a parasite called ...
The Lancet5d
Advancing policies for rare diseases in Europe
Fostering dialogue between neurologists, researchers, patient representatives, and policymakers is an important step towards ...
Ontario Brain Institute partners with EpiSign to advance diagnosis of rare genetic...
CNW/ - The Ontario Brain Institute (OBI) is pleased to announce a joint new initiative with EpiSign Inc., paving the way for improved diagnosis and care ...